Skip to main content
Equibles

Stéphanie Cornen

Head of Investor Relations

Innate Pharma SA (IPHA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Innate Pharma SA publishes a filing, an earnings call transcript or a press release.

Get IPHA alerts

About Stéphanie Cornen

Stéphanie Cornen is recorded as Head of Investor Relations at Innate Pharma SA (IPHA). Stéphanie Cornen has spoken on 5 earnings calls and 2 other investor events across 1 company, most recently for Innate Pharma SA on November 5, 2026. Innate Pharma SA is classified in the Biotechnology industry within the Healthcare sector.

Stéphanie Cornen on recent calls

“Thank you for joining us for Innate Pharma's third quarter 2026 business update and financial results conference call. The press release and today's presentation are both available on the IOP section of our website.”
Head of Investor Relations, Innate Pharma SA Q3 FY2026 Earnings Call ·
“Thank you for joining us for Innate Pharma's first half, 2026, Business Update and Financial Results Conference Call. The press release and today's presentation are both available on the IR section of our website.”
Head of Investor Relations, Innate Pharma SA Q2 FY2026 Earnings Call ·
“Thank you, R.K. So, indeed, I think that some parts of the innate theory are still underappreciated. One good example of this was lacutamab. We have spent the past 12 months with Jonathan and Yanis trying to raise awareness about what is the CTCL market.”
Head of Investor Relations, H.C. Wainwright 28th Annual Global Investment Conference ·
“Thank you for joining us for Innate Pharma's Q1 2026 business update and financial results conference call. The press release and today's presentation are both available on the IR section of our website.”
Head of Investor Relations, Earnings conference call (announced in 6-K) ·
“Good morning and good afternoon, everyone, and thank you for joining us for Innate Pharma's full year 2025 Business Update and Financial Results Conference Call.”
Head of Investor Relations, Innate Pharma SA Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Recent activity